window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Opinion & Events

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Imagene AI and Sheba Medical Center form alliance to expand precision oncology with real-world data

    Imagene AI has expanded its collaboration with Sheba Medical Center [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    Cook MyoSite and Veristat progress Phase 3 trial of cell therapy for women with chronic incontinence

    Cook MyoSite and Veristat have reached a key enrolment milestone [...]

    May 5, 2026
  • Clinical & Regulatory,Medical devices,Opinion & Events

    New study shows IntelliSep test improves early sepsis detection and boosts SEP-1 compliance by 29%

    A study presented at the American College of Emergency Physicians [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    Discover Pharma thrilled to be a media partner at CPHI Frankfurt 2025

    At not even six months old, the small team at [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    CPHI Frankfurt’s puts spotlight on innovation, partnerships and sustainability – an interview with event director, Tara Dougal

    As CPHI Frankfurt 2025 prepares to welcome more than 60,000 [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Opinion & Events,Pharmaceuticals and therapeutics

    Kling Bio and Sanofi join forces to speed discovery of neutralizing antibodies

    Kling Bio has announced a collaboration and license option agreement [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    UK clears Mainz Biomed’s ColoAlert for colorectal cancer screening

    Mainz Biomed has received official registration from the UK Medicines [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Medical devices,Opinion & Events

    ViCentra raises $85M to scale manufacturing and accelerate market penetration of Kaleido insulin patch pump

    ViCentra, a European medical device company redefining insulin delivery for [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Opinion & Events,Pharmaceuticals and therapeutics

    Terumo BCT and PwC Belgium join forces to break barriers in access to advanced cell and gene therapies

    Terumo Blood and Cell Technologies (Terumo BCT), a medical technology [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Manufacturing & Supply Chain,Opinion & Events

    Gifthealth acquires Occam Health to expand digital pharmacy and patient access services

    Gifthealth has acquired Occam Health Services in a move that [...]

    May 5, 2026
Previous789Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development
  • Weite Oldenziel
    Ofichem unifies CDMO and pharmaceutical supply brands under single identity
    Categories: Manufacturing & Supply Chain
  • DeepCyte raises $1.5M to advance single-cell AI toxicology platform for drug development
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top